• Cite/Export
  Cite/Export

  Copy a citation

  APA (6th ed.)

  

  Chicago (Author-Date, 15th ed.)

  

  Harvard (18th ed.)

  

  MLA (7th ed.)

  

  Turabian (6th ed.)

  

  Export a citation

  Export to RefWorks   Export to EndNote / Reference Manager   Export to EasyBib
  Export to EndNote / Reference Manager(non-Latin)   Cancel

  Note: Citations are based on reference standards. However, formatting rules can vary widely between applications and fields of interest or study. The specific requirements or preferences of your reviewing publisher, classroom teacher, institution or organization should be applied.
• Print
• E-mail
  E-mail

  All fields are required.

  The E-mail Address(es) field is required. Please enter recipient e-mail address(es).

  The E-mail Address(es) you entered is(are) not in a valid format. Please re-enter recipient e-mail address(es).

  You may send this item to up to five recipients.

  Enter recipient e-mail address(es): Separate up to five addresses with commas (,)

  The name field is required. Please enter your name.

  Enter your name: The subject field is required. Please enter the subject. Subject:

  The E-mail message field is required. Please enter the message.

  E-mail Message: I thought you might be interested in this item at http://www.worldcat.org/oclc/6892890974 Title: Genetic determinants of Von Willebrand factor and the risk of cardiovascular disease Publisher: Erasmus University Rotterdam 2012-11-09 ISBN/ISSN: 978-94-6169-293-1 OCLC:6892890974

  
  

  Please verify that you are not a robot.

  Cancel
• Share
• Permalink
  Permalink

  Copy this URL to link to this page:

• Write a review
• Rate this item:
• • 1
  • 2
  • 3
  • 4
  • 5

Genetic determinants of Von Willebrand factor and the risk of cardiovascular disease

Author:	Janine Loon
Publisher:	Erasmus University Rotterdam 2012-11-09
Edition/Format:	Book : English
Summary:	textabstractNormal haemostasis requires a delicate balance between procoagulant and anticoagulantfactors. Disruption of this balance may lead to bleeding disorders, such as hemophilia,or thrombotic disorders, including deep vein thrombosis of the leg. As Virchowalready reported in 1877, properties of the blood vessel wall, the blood flow and bloodconstituents contribute to the formation of thrombi in either veins or arteries. However,through contemporary research the complexity of this process leading to thrombusformation has become more apparent.An important player in thrombus formation is von Willebrand Factor (VWF), a largemultifunctional glycoprotein. VWF initiates adherence of platelets to the injured vesselwall and subsequent platelet aggregation leading inevitably to the formation ofthrombi. In addition, VWF is a carrier protein of coagulation factor VIII (FVIII), therebyprotecting it from clearance.In healthy subjects normal plasma VWF levels range from 0.60 – 1.40 IU/mL and arecharacterized by a large variation. This can be partly attributed to a number of lifestyleand environmental factors, but most importantly to genetic factors.The necessity of maintaining normal VWF levels in the circulation is illustrated bytwo clinical manifestations that may occur when VWF exceeds its normal range. Lowlevels of VWF may lead to bleeding, which is known as von Willebrand Disease (VWD),the most common inherited bleeding disorder in humans. To the contrary, high VWFantigen (VWF:Ag) levels are associated with an increased risk of venous thrombosisand arterial thrombosis, including myocardial infarction (MI) and ischemic stroke.  Read more...
Rating:	(not yet rated) 0 with reviews - Be the first.